Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novanta (NOVT) Gains from Sales and Divestitures (2016 - 2025)

Historic Gains from Sales and Divestitures for Novanta (NOVT) over the last 14 years, with Q3 2025 value amounting to $91000.0.

  • Novanta's Gains from Sales and Divestitures fell 1078.43% to $91000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $91000.0, marking a year-over-year decrease of 1078.43%. This contributed to the annual value of $107000.0 for FY2024, which is 183.49% down from last year.
  • According to the latest figures from Q3 2025, Novanta's Gains from Sales and Divestitures is $91000.0, which was down 1078.43% from $83000.0 recorded in Q2 2025.
  • In the past 5 years, Novanta's Gains from Sales and Divestitures ranged from a high of $487000.0 in Q4 2021 and a low of $72000.0 during Q1 2025
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $102000.0 (2023), whereas its average is $162894.7.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first surged by 30583.33% in 2021, then plummeted by 7216.49% in 2022.
  • Over the past 5 years, Novanta's Gains from Sales and Divestitures (Quarter) stood at $487000.0 in 2021, then plummeted by 67.97% to $156000.0 in 2022, then crashed by 30.13% to $109000.0 in 2023, then decreased by 1.83% to $107000.0 in 2024, then decreased by 14.95% to $91000.0 in 2025.
  • Its Gains from Sales and Divestitures was $91000.0 in Q3 2025, compared to $83000.0 in Q2 2025 and $72000.0 in Q1 2025.